Abstract
Macrocyclic peptides (MPs) are valued molecules in chemical biology due to their high affinity, enhanced stability, and favorable pharmacological properties. However, their broader utility faces limitations. Current cyclization methods often afford restricted structural diversity, which hinders discovery. Here we report a general multicomponent macrocyclization strategy based on the Betti reaction that enables lysine-selective modification and ring closure under mild, peptide-compatible conditions. The reaction tolerates a wide range of aldehydes, carbon nucleophiles, and amino acid contexts, and proceeds efficiently in both solution and on solid support. These features allow the rapid generation of structurally diverse macrocycles with high conversions and substantially improved proteolytic stability. Using this platform, we constructed a 30-member cyclic RGD library and identified several macrocycles with adhesion-blocking activities comparable to or surpassing Cilengitide across two integrin-expressing cell lines. We further demonstrated the modularity of this chemistry by conjugating an optimized RGD macrocycle to the pro-apoptotic peptide KLA, producing a hybrid construct with enhanced cellular uptake, mitochondrial depolarization, and apoptosis induction. Together, these results establish Betti multicomponent macrocyclization as a versatile and powerful method for creating functional macrocycles and modular therapeutic peptide architectures.
Supplementary materials
Title
Supporting Information
Description
Description of general solid-phase synthesis procedures, data for compound characterization, supplementary figures and table, and details of biological assays (PDF)
Actions



![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://www.cambridge.org/engage/assets/public/coe/logo/orcid.png)